The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).

Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!

Resource Search

Search Results

MPTs & the IMPT Platform

MPTs & the IMPT Platform

MPTs & the IMPT Platform May 2021 The MPTs & the IMPT Platform is a PowerPoint presentation created by the IMPT Secretariat at CAMI Health to help our colleagues integrate MPTs into their talks and presentations. Please email IMPT@cami-health.org with any feedback on how you used this information. Download the presentation slide deck CAMI Health […]

IMPT, CAMI Health May 2021
MPT Investment Case Slide Deck

MPT Investment Case Slide Deck

CAMI Health January 2019
Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV – Power Point

Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV – Power Point

Multipurpose Prevention Technologies (MPTs): a promising response to current challenges around hormonal contraceptive methods & HIV – Power Point 27 January 2016 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education MPTs Region(s): Global

Vogelsong, K., Polis, C., Hemmerling, A., & Dellplain, L. Visit Presentation January 2016
Multipurpose Prevention Technologies (MPTs): Developing interventions to simultaneously prevent STIs, HIV and Pregnancy – Presentation

Multipurpose Prevention Technologies (MPTs): Developing interventions to simultaneously prevent STIs, HIV and Pregnancy – Presentation

Multipurpose Prevention Technologies (MPTs): Developing interventions to simultaneously prevent STIs, HIV and Pregnancy – Presentation 16 September 2015 Panel session at the 2015 ISSTDR World STI & HIV Congress in Brisbane, Australia Co-sponsored by the World Health Organization (WHO), the University of California San Francisco (UCSF) Bixby Center, the Initiative for MPTs (IMPT), and the […]

Kong M., Black V., Schelar E., Mmeje O., Haire B. September 2015
Multipurpose Prevention Technologies (MPTs): New reproductive health products on the horizon

Multipurpose Prevention Technologies (MPTs): New reproductive health products on the horizon

Multipurpose Prevention Technologies (MPTs): New reproductive health products on the horizon 07 October 2015 Panel session during the New and Underused Reproductive Health Technologies (NURHT) Caucus at the 2015 Reproductive Health Supplies Coalition (RHSC) General Membership Meeting, in Oslo, Norway The session provided an overview of the MPT product development pipeline, and addressed key questions […]

Young Holt, B., Light, B., Wood Santos, T., October 2015
New Developments in Barrier Contraception: Implications for Multipurpose Prevention Technologies (MPTs)

New Developments in Barrier Contraception: Implications for Multipurpose Prevention Technologies (MPTs)

New Developments in Barrier Contraception: Implications for Multipurpose Prevention Technologies (MPTs) 14 November 2015 Panel session at the 2015 North American Forum on Family Planning in Chicago, IL This panel presented on the promising application of new contraceptive barrier methods in MPT development, and provided an outline of the MPT field as a whole. Presenters: […]

Young Holt, B., Forcier, M., November 2015
MPTs: What Are they, and Why Are they Needed?

MPTs: What Are they, and Why Are they Needed?

MPTs: What Are they, and Why Are they Needed? October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Advocacy Product Development Risk

Manning, J. Visit Presentation October 2014
State of the Art: Multipurpose Prevention Technology Science and Product Development

State of the Art: Multipurpose Prevention Technology Science and Product Development

State of the Art: Multipurpose Prevention Technology Science and Product Development October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development

Romano, J. Visit Presentation October 2014
Regulatory Considerations with Developing Combination Products

Regulatory Considerations with Developing Combination Products

Regulatory Considerations with Developing Combination Products October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Product Type(s): MPTs Topic(s): Product Development Regulatory Issues

Mullick, C. Visit Presentation October 2014
Study Designs for Evaluating the Effectiveness of Multipurpose Technologies

Study Designs for Evaluating the Effectiveness of Multipurpose Technologies

Study Designs for Evaluating the Effectiveness of Multipurpose Technologies October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials

Brown, E. Visit Presentation October 2014
Multipurpose Prevention Technologies

Multipurpose Prevention Technologies

Multipurpose Prevention Technologies October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Social/Behavioral Context

Bukusi, E. Visit Presentation October 2014
Round Table Discussion: Multipurpose Prevention Technologies

Round Table Discussion: Multipurpose Prevention Technologies

Round Table Discussion: Multipurpose Prevention Technologies October 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Risk Social/Behavioral Context

Manning, J., Romano, J., Mullick, C., Brown, E., & Bukusi, E. Visit Presentation October 2014
Multipurpose Prevention Technologies: Impact Investing for Global Reproductive Health

Multipurpose Prevention Technologies: Impact Investing for Global Reproductive Health

Multipurpose Prevention Technologies: Impact Investing for Global Reproductive Health 05 September 2014 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Collective Impact MPTs Product Development Risk

Young Holt, B., Lusti-Narasimhan, M., Romano, J., Vyda, L., & Wood-Santos, T. Visit Presentation September 2014
Women’s Health in Women’s Hands: The Promise of MPTs

Women’s Health in Women’s Hands: The Promise of MPTs

Women’s Health in Women’s Hands: The Promise of MPTs 02 July 2014 The Stewart Center West at UCSF ANSIRH Oakland, CA CAMI hosted a panel and reception featuring Manjula Lusti-Narasimhan (WHO), Ina Park (CDPH/UCSF), Bethany Young Holt (CAMI/PHI) and others to discuss innovative prevention strategies that can simultaneously address risk for unintended pregnancies and STIs, […]

Bethany Young Holt, Manjula Lusti-Narasimhan, Ina Park July 2014
SILCS in South Africa: Opportunities for introduction as a barrier contraceptive and as an MPT

SILCS in South Africa: Opportunities for introduction as a barrier contraceptive and as an MPT

SILCS in South Africa: Opportunities for introduction as a barrier contraceptive and as an MPT November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Diaphragm MPTs Topic(s): Product Development Product Trials

Smit, J. Visit Presentation November 2013
MPTs available now and on the horizon

MPTs available now and on the horizon

MPTs available now and on the horizon May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development

Shields, W. Visit Presentation May 2013
Regional Priorities for Multipurpose Prevention Technologies: the Epidemiological and Demographic Data

Regional Priorities for Multipurpose Prevention Technologies: the Epidemiological and Demographic Data

Regional Priorities for Multipurpose Prevention Technologies: the Epidemiological and Demographic Data November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Product Development

Lusti-Narasimhan, M. Visit Presentation November 2013
Aligning investments in MPT R&D and the critical path to MPT introduction

Aligning investments in MPT R&D and the critical path to MPT introduction

Aligning investments in MPT R&D and the critical path to MPT introduction May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development

Manning, J. & Romano, J. Visit Presentation May 2013
The Reality on the Ground: What Users and Providers Want and Need in MPTs

The Reality on the Ground: What Users and Providers Want and Need in MPTs

The Reality on the Ground: What Users and Providers Want and Need in MPTs November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Social/Behavioral Context

Bukusi, E. Visit Presentation November 2013
HIV Prevention and MPT Product Pipeline Update

HIV Prevention and MPT Product Pipeline Update

HIV Prevention and MPT Product Pipeline Update 03 April 2013 click to view Presentation In this Presentation: Health Risk(s): HIV Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development

Romano, J. Visit Presentation April 2013
Indian women’s perceptions of vaginal rings-feedback for development of multipurpose prevention technologies

Indian women’s perceptions of vaginal rings-feedback for development of multipurpose prevention technologies

Indian women’s perceptions of vaginal rings-feedback for development of multipurpose prevention technologies November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): Product Development Product Trials Social/Behavioral Context

Das, U., Sharma, M., Kilbourne-Brook, M., & Coffey, P.S. Visit Presentation November 2013
Multipurpose Prevention Technologies (MPTs) for Sexual and Reproductive Health

Multipurpose Prevention Technologies (MPTs) for Sexual and Reproductive Health

Multipurpose Prevention Technologies (MPTs) for Sexual and Reproductive Health September 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education Product Development

Young Holt, B. Visit Presentation September 2013
Multipurpose Prevention Technologies (MPTs) for Girls and Women: Introduction

Multipurpose Prevention Technologies (MPTs) for Girls and Women: Introduction

Multipurpose Prevention Technologies (MPTs) for Girls and Women: Introduction 30 May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education Product Development

Hemmerling, A. & Chatani, M. Visit Presentation May 2013
What are MPTs and why do we need them? What’s available now and on the horizon – Chandhiok

What are MPTs and why do we need them? What’s available now and on the horizon – Chandhiok

What are MPTs and why do we need them? What’s available now and on the horizon – Chandhiok 30 May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education Product Development

Chandhiok, N. Visit Presentation May 2013
A Critical Look Down the Critical Path to MPT Development

A Critical Look Down the Critical Path to MPT Development

A Critical Look Down the Critical Path to MPT Development 20-21 February 2013 Washington, DC, USA click to view Presentation In this Presentation: Health Risk(s): General SRH Product Type(s): MPTs Topic(s): Regulatory Issues Region(s): Global Working Group(s): Other

Brady, M. Visit Presentation February 2013
Supporting Agency Coordination and Cooperation in the Development of Contraceptive Methods Appropriate for Provision and Use in Low Resource Settings

Supporting Agency Coordination and Cooperation in the Development of Contraceptive Methods Appropriate for Provision and Use in Low Resource Settings

Supporting Agency Coordination and Cooperation in the Development of Contraceptive Methods Appropriate for Provision and Use in Low Resource Settings November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Contraceptives Topic(s): Product Development

Manning, J., Blithe, D., & Vogelsong, K. Visit Presentation November 2013
Microbicides, where are we today?

Microbicides, where are we today?

Microbicides, where are we today? 30 May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Microbicides MPTs Topic(s): Product Development Product Trials

Rosenberg, Z. Visit Presentation May 2013
Introducing Novel Technologies at the Country Level; Promoting Approval, Access and Acceptance

Introducing Novel Technologies at the Country Level; Promoting Approval, Access and Acceptance

Introducing Novel Technologies at the Country Level; Promoting Approval, Access and Acceptance November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Contraceptives Topic(s): Social/Behavioral Context SRH Linkages

Bukusi, E. Visit Presentation November 2013
Aligning investments in MPT Research & Development

Aligning investments in MPT Research & Development

Aligning investments in MPT Research & Development May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development

Manning, J. Visit Presentation May 2013
The Development of Two Multipurpose Prevention Technology (MPT) Products, the Regulatory Pathway for Each, and the Initiation of Clinical Studies

The Development of Two Multipurpose Prevention Technology (MPT) Products, the Regulatory Pathway for Each, and the Initiation of Clinical Studies

The Development of Two Multipurpose Prevention Technology (MPT) Products, the Regulatory Pathway for Each, and the Initiation of Clinical Studies November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials Regulatory Issues

Callahan, M., Schwartz, J., Friend, D., & Clark, M. Visit Presentation November 2013
What do these technologies mean for women living with HIV?

What do these technologies mean for women living with HIV?

What do these technologies mean for women living with HIV? May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Social/Behavioral Context

Caswell, G. Visit Presentation May 2013
MPTs: Assessing Acceptability and Adherence

MPTs: Assessing Acceptability and Adherence

MPTs: Assessing Acceptability and Adherence November 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Social/Behavioral Context

Tolley, E. Visit Presentation November 2013
What are MPTs and why do we need them? What’s available now and on the horizon – Rees

What are MPTs and why do we need them? What’s available now and on the horizon – Rees

What are MPTs and why do we need them? What’s available now and on the horizon – Rees May 2013 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Product Development

Rees, H. Visit Presentation May 2013
Regulatory Pathways for MPTs: Distilling and Clarifying the Process

Regulatory Pathways for MPTs: Distilling and Clarifying the Process

Regulatory Pathways for MPTs: Distilling and Clarifying the Process 11 January 2012 click to view Presentation In this Presentation: Health Risk(s): General SRH Product Type(s): MPTs Topic(s): Regulatory Issues

Brady, M. Visit Presentation January 2012
Potential for increasing use of barrier methods in India

Potential for increasing use of barrier methods in India

Potential for increasing use of barrier methods in India December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Condoms Topic(s): Reproductive Health

Aggarwal, D. Visit Presentation December 2012
Users’ and Providers’ Perspectives on MPTs: What do we know, and what do we need to know?

Users’ and Providers’ Perspectives on MPTs: What do we know, and what do we need to know?

Users’ and Providers’ Perspectives on MPTs: What do we know, and what do we need to know? December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Regulatory Issues Social/Behavioral Context

Brady, M. Visit Presentation December 2012
From Ideal to Real: The MPT R&D Pipeline

From Ideal to Real: The MPT R&D Pipeline

From Ideal to Real: The MPT R&D Pipeline December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials

Manning, J. Visit Presentation December 2012
Involving End Users and Health System in the Development of/Access to MPTs: The Indian context

Involving End Users and Health System in the Development of/Access to MPTs: The Indian context

Involving End Users and Health System in the Development of/Access to MPTs: The Indian context December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Social/Behavioral Context

Bharat, S. Visit Presentation December 2012
BioRings Vaginal Ring

BioRings Vaginal Ring

BioRings Vaginal Ring December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): IVR (Intravaginal Rings) MPTs Topic(s): Product Development Product Trials

Singh, M. Visit Presentation December 2012
Availability, Access and Utilization of MPTs: Issues and Challenges

Availability, Access and Utilization of MPTs: Issues and Challenges

Availability, Access and Utilization of MPTs: Issues and Challenges December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Introduction / Uptake Social/Behavioral Context

Bachani, D. Visit Presentation December 2012
Review of MPTs in the Product Development Pipeline – Indian Perspective

Review of MPTs in the Product Development Pipeline – Indian Perspective

Review of MPTs in the Product Development Pipeline – Indian Perspective December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development Product Trials

Gupta, S. Visit Presentation December 2012
Availability and Access of MPTs: Implementation Issues

Availability and Access of MPTs: Implementation Issues

Availability and Access of MPTs: Implementation Issues December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Introduction / Uptake

Sood, B. Visit Presentation December 2012
Meeting objectives: Symposium on accelerating research on MPTs

Meeting objectives: Symposium on accelerating research on MPTs

Meeting objectives: Symposium on accelerating research on MPTs December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education

Chandhiok, N. Visit Presentation December 2012
The Effect of Intervaginal Basant in Patients with Cervical Intraepithelical Neoplasma and HPV DNA

The Effect of Intervaginal Basant in Patients with Cervical Intraepithelical Neoplasma and HPV DNA

The Effect of Intervaginal Basant in Patients with Cervical Intraepithelical Neoplasma and HPV DNA December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV Other Product Type(s): Microbicides Topic(s): Product Trials

Talwar, G.P. Visit Presentation December 2012
Availability & Access of MPTs: Implementation Issues Innovative partnerships/business models

Availability & Access of MPTs: Implementation Issues Innovative partnerships/business models

Availability & Access of MPTs: Implementation Issues Innovative partnerships/business models December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Introduction / Uptake Public-Private Partnerships

Washington, R. Visit Presentation December 2012
The New Horizon

The New Horizon

The New Horizon December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Education

Manning, J. Visit Presentation December 2012
Communication Tools to Advance Support for Multipurpose Prevention Technologies (MPTs) in India Using a Messaging Framework to Coordinate Advocacy of MPTs

Communication Tools to Advance Support for Multipurpose Prevention Technologies (MPTs) in India Using a Messaging Framework to Coordinate Advocacy of MPTs

Communication Tools to Advance Support for Multipurpose Prevention Technologies (MPTs) in India Using a Messaging Framework to Coordinate Advocacy of MPTs December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Advocacy

Cohen, J. Visit Presentation December 2012
The Need for MPTs: Global overview of epidemiological trends and rationale for MPTs

The Need for MPTs: Global overview of epidemiological trends and rationale for MPTs

The Need for MPTs: Global overview of epidemiological trends and rationale for MPTs December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Product Development

Lusti-Narasimhan, M. Visit Presentation December 2012
Identification of Key Attributes and Prioritization of Product Development

Identification of Key Attributes and Prioritization of Product Development

Identification of Key Attributes and Prioritization of Product Development December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Product Development

Manning, J., Romano, J. Visit Presentation December 2012
HIV-1, STDs and RH situation in China and the need for MPT

HIV-1, STDs and RH situation in China and the need for MPT

HIV-1, STDs and RH situation in China and the need for MPT December 2012 click to view Presentation In this Presentation: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): Epidemiology Product Development

Wu, A. Visit Presentation December 2012